Funded Tech Companies
Unum Therapeutics
Wondering who provided funding to Unum Therapeutics? OrbiMed, BVF Partners and Ally Bridge Group joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Unum Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
200 Cambridge Park Dr. 3100
Cambridge, MA 02140
USA
Cambridge, MA 02140
USA
Phone
Website
Email Address
Company Background Information
Overview
Unum Therapeutics uses proprietary T-cell engineering technology in combination with tumor-targeting antibodies to activate the body's own immune system to fight cancer.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/10/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chuck Wilson
Chief Financial Officer
John Green
Chief Medical Officer
Jessica Sachs
VP - Human Resources
Erin Schellhammer
VP - Operations
Larry Weiner
VP - R & D
Gregory Motz
VP - Regulatory Affairs
Todd Kenney
Company Investors
- OrbiMed
- BVF Partners
- Ally Bridge Group
- Acorn Bioventures
- Atlas Venture (Bruce Booth)
- Venrock
- Commodore Capital
- Logos Capital
- Samsara BioCapital
- RTW Investments
- Perceptive Advisors
- Fairmount Funds Management (Peter Harwin)
- Square 1 Bank (Scott Hansen)
- Brace Pharma
- Sanofi-Genzyme BioVentures
- Novo Ventures
- New Leaf Venture Partners (Liam Ratcliffe)
- Sabby Capital
- Cowen Capital Partners
- Wellington Management Company
- F-Prime Capital (Benjamin Auspitz)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs